{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:56:00Z","timestamp":1777301760226,"version":"3.51.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Duke FORGE Fellowship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Digital medicine is an interdisciplinary field, drawing together stakeholders with expertize in engineering, manufacturing, clinical science, data science, biostatistics, regulatory science, ethics, patient advocacy, and healthcare policy, to name a few. Although this diversity is undoubtedly valuable, it can lead to confusion regarding terminology and best practices. There are many instances, as we detail in this paper, where a single term is used by different groups to mean different things, as well as cases where multiple terms are used to describe essentially the same concept. Our intent is to clarify core terminology and best practices for the evaluation of Biometric Monitoring Technologies (BioMeTs), without unnecessarily introducing new terms. We focus on the evaluation of BioMeTs as fit-for-purpose for use in clinical trials. However, our intent is for this framework to be instructional to all users of digital measurement tools, regardless of setting or intended use. We propose and describe a three-component framework intended to provide a foundational evaluation framework for BioMeTs. This framework includes (1) verification, (2) analytical validation, and (3) clinical validation. We aim for this common vocabulary to enable more effective communication and collaboration, generate a common and meaningful evidence base for BioMeTs, and improve the accessibility of the digital medicine field.<\/jats:p>","DOI":"10.1038\/s41746-020-0260-4","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T06:03:12Z","timestamp":1586844192000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":452,"title":["Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs)"],"prefix":"10.1038","volume":"3","author":[{"given":"Jennifer C.","family":"Goldsack","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5379-3540","authenticated-orcid":false,"given":"Andrea","family":"Coravos","sequence":"additional","affiliation":[]},{"given":"Jessie P.","family":"Bakker","sequence":"additional","affiliation":[]},{"given":"Brinnae","family":"Bent","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7889-4978","authenticated-orcid":false,"given":"Ariel V.","family":"Dowling","sequence":"additional","affiliation":[]},{"given":"Cheryl","family":"Fitzer-Attas","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4049-9291","authenticated-orcid":false,"given":"Alan","family":"Godfrey","sequence":"additional","affiliation":[]},{"given":"Job G.","family":"Godino","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7901-308X","authenticated-orcid":false,"given":"Ninad","family":"Gujar","sequence":"additional","affiliation":[]},{"given":"Elena","family":"Izmailova","sequence":"additional","affiliation":[]},{"given":"Christine","family":"Manta","sequence":"additional","affiliation":[]},{"given":"Barry","family":"Peterson","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0672-0327","authenticated-orcid":false,"given":"Benjamin","family":"Vandendriessche","sequence":"additional","affiliation":[]},{"given":"William A.","family":"Wood","sequence":"additional","affiliation":[]},{"given":"Ke Will","family":"Wang","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3241-8183","authenticated-orcid":false,"given":"Jessilyn","family":"Dunn","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,4,14]]},"reference":[{"key":"260_CR1","unstructured":"Goldsack, J. Laying the Foundation: Defining Digital Medicine. Medium (2019). Available at: https:\/\/medium.com\/digital-medicine-society-dime\/laying-the-foundation-defining-digital-medicine-49ab7b6ab6ef. (Accessed 18 Sept 2019)."},{"key":"260_CR2","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1016\/S2589-7500(19)30001-9","volume":"1","author":"E Perakslis","year":"2019","unstructured":"Perakslis, E. & Coravos, A. Is health-care data the new blood? Lancet Digital Health 1, e8\u2013e9 (2019).","journal-title":"Lancet Digital Health"},{"key":"260_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000500413","volume":"3","author":"A Coravos","year":"2019","unstructured":"Coravos, A. et al. Digital medicine: a primer on measurement. Digit Biomark. 3, 31\u201371 (2019).","journal-title":"Digit Biomark."},{"key":"260_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2217\/pme-2018-0044","volume":"15","author":"J Dunn","year":"2018","unstructured":"Dunn, J., Runge, R. & Snyder, M. Wearables and the medical revolution. Per. Med. 15, 429\u2013448 (2018).","journal-title":"Per. Med."},{"key":"260_CR5","unstructured":"FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource. (Food and Drug Administration (US), 2016)."},{"key":"260_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/bmj.305.6846.187-b","volume":"305","author":"E Versi","year":"1992","unstructured":"Versi, E. \u2018Gold standard\u2019 is an appropriate term. BMJ 305, 187 (1992).","journal-title":"BMJ"},{"key":"260_CR7","unstructured":"14:00-17:00. ISO 9001:2015. ISO Available at: http:\/\/www.iso.org\/cms\/render\/live\/en\/sites\/isoorg\/contents\/data\/standard\/06\/20\/62085.html. (Accessed 18 Sept 2019)."},{"key":"260_CR8","unstructured":"International Organization for Standardization & International Electrotechnical Commission. ISO 13485:2016, Medical devices \u2014 Quality management systems \u2014 Requirements for regulatory purposes. (2016)."},{"key":"260_CR9","doi-asserted-by":"publisher","unstructured":"IEEE Computer Society. IEEE Standard for System, Software, and Hardware Verification and Validation. IEEE Std 1012-2016 (Revision of IEEE Std 1012-2012\/ Incorporates IEEE Std 1012-2016\/Cor1-2017) 1\u2013260 (2017). https:\/\/doi.org\/10.1109\/IEEESTD.2017.8055462.","DOI":"10.1109\/IEEESTD.2017.8055462"},{"key":"260_CR10","unstructured":"U.S. Department Of Health and Human Services, U.S. Food and Drug Administration, Center for Devices and Radiological Health & Center for Biologics Evaluation and Research. General Principles of Software Validation; Final Guidance for Industry and FDA Staff, 47 (2002)."},{"key":"260_CR11","unstructured":"U.S. Food and Drug Administration. CFR - Code of Federal Regulations Title 21. Available at: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=820.30. (Accessed 18 Sept 2019)."},{"key":"260_CR12","unstructured":"Center for Drug Evaluation and Research. Drug Development Tool Qualification Programs. FDA (2019). Available at: http:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/drug-development-tool-qualification-programs. (Accessed 18 Sept 2019)."},{"key":"260_CR13","unstructured":"U.S. Food and Drug Administration. Bioanalytical Method Validation Guidance for Industry. Available at: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/bioanalytical-method-validation-guidance-industry. (Accessed 7 Mar 2020)."},{"key":"260_CR14","unstructured":"Clinical Trials Transformation Initiative. Framework of Specifications to Consider During Mobile Technology Selection (2018)."},{"key":"260_CR15","unstructured":"H.R. 34, 114th Congress. 21st Century Cures Act (2016)."},{"key":"260_CR16","unstructured":"U.S. Food and Drug Administration. Digital Health Innovation Action Plan. (2017). https:\/\/www.fda.gov\/media\/106331\/download."},{"key":"260_CR17","unstructured":"IMDRF SaMD Working Group. Software as a Medical Device (SaMD): Key definitions (2017)."},{"key":"260_CR18","unstructured":"Krueger, A. C. Regulation of photoplethysmograph analysis software for over-the-counter use. U.S. Food & Drug Administration (2018)."},{"key":"260_CR19","unstructured":"Krueger, A. C. Regulation of electrocardiograph software for over-the-counter use. U.S. Food & Drug Administration (2018)."},{"key":"260_CR20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1136\/jclinpath-2016-203958","volume":"70","author":"GE Bignardi","year":"2017","unstructured":"Bignardi, G. E. Validation and verification of automated urine particle analysers. J. Clin. Pathol. 70, 94\u2013101 (2017).","journal-title":"J. Clin. Pathol."},{"key":"260_CR21","unstructured":"International Electrotechnical Commission. Available at: https:\/\/www.iec.ch\/. (Accessed 18 Sept 2019)."},{"key":"260_CR22","unstructured":"Margaine, C. The Notified Body\u2019s Role in Medical Device Certification. Available at: https:\/\/lne-america.com\/certification\/ce-marking-gain-market-access-to-europe\/notified-body. (Accessed 18 Sept 2019)."},{"key":"260_CR23","unstructured":"USP (The United States Pharmacopeial Convention). Available at: https:\/\/www.usp.org\/. (Accessed 18 Sept 2019)."},{"key":"260_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.cobme.2019.01.001","volume":"9","author":"DR Witt","year":"2019","unstructured":"Witt, D. R., Kellogg, R. A., Snyder, M. P. & Dunn, J. Windows into human health through wearables data analytics. Curr. Opin. Biomed. Eng. 9, 28\u201346 (2019).","journal-title":"Curr. Opin. Biomed. Eng."},{"key":"260_CR25","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.gaitpost.2012.02.019","volume":"36","author":"J McCamley","year":"2012","unstructured":"McCamley, J., Donati, M., Grimpampi, E. & Mazz\u00e0, C. An enhanced estimate of initial contact and final contact instants of time using lower trunk inertial sensor data. Gait Posture 36, 316\u2013318 (2012).","journal-title":"Gait Posture"},{"key":"260_CR26","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.gaitpost.2014.07.007","volume":"40","author":"D Trojaniello","year":"2014","unstructured":"Trojaniello, D., Cereatti, A. & Della Croce, U. Accuracy, sensitivity and robustness of five different methods for the estimation of gait temporal parameters using a single inertial sensor mounted on the lower trunk. Gait Posture 40, 487\u2013492 (2014).","journal-title":"Gait Posture"},{"key":"260_CR27","doi-asserted-by":"crossref","unstructured":"Hutchinson, L. et al. Operator bias errors are reduced using standing marker alignment device for repeated visit studies. J. Biomech. Eng. 140, 041001 (2018).","DOI":"10.1115\/1.4038358"},{"key":"260_CR28","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.medengphy.2015.02.003","volume":"37","author":"A Godfrey","year":"2015","unstructured":"Godfrey, A., Del Din, S., Barry, G., Mathers, J. C. & Rochester, L. Instrumenting gait with an accelerometer: a system and algorithm examination. Med. Eng. Phys. 37, 400\u2013407 (2015).","journal-title":"Med. Eng. Phys."},{"key":"260_CR29","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1712231","volume":"378","author":"JR Banegas","year":"2018","unstructured":"Banegas, J. R. et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. N. Engl. J. Med. 378, 1509\u20131520 (2018).","journal-title":"N. Engl. J. Med."},{"key":"260_CR30","unstructured":"U.S. Department of Health and Human Services, U.S. Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER) & Center for Devices and Radiological Health (CDRH). Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. (2009)."},{"key":"260_CR31","unstructured":"Clinical Trials Transformation Initiative. CTTI Recommendations: Developing Novel Endpoints Generated by Mobile Technology for Use in Clinical Trials. (2017)."},{"key":"260_CR32","unstructured":"U.S. Department of Health and Human Services, U.S. Food and Drug Administration, Center for Drug Evaluation and Research (CDER) & Center for Biologics Evaluation and Research (CBER). Biomarker Qualification: Evidentiary Framework Guidance for Industry and FDA Staff. (2018)."},{"key":"260_CR33","unstructured":"Clinical Trials Transformation Initiative. Quick Reference Guide to Processings for Interacting with the US Food and Drug Administration (FDA) regarding Novel Endpoint Development. (2017)."},{"key":"260_CR34","unstructured":"U.S. Food and Drug Administration. FDA Fact Sheet: The FDA\u2019S Role in Medical Device Cybersecurity, Dispelling Myths and Understanding Facts."},{"key":"260_CR35","doi-asserted-by":"publisher","unstructured":"Huynh, Q. T., Nguyen, U. D., Irazabal, L. B., Ghassemian, N. & Tran, B. Q. Optimization of an accelerometer and gyroscope-based fall detection algorithm. J. Sens. (2015). https:\/\/doi.org\/10.1155\/2015\/452078.","DOI":"10.1155\/2015\/452078"},{"key":"260_CR36","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3389\/fneur.2018.00652","volume":"9","author":"MH Pham","year":"2018","unstructured":"Pham, M. H. et al. Validation of a lower back \u201cwearable\u201d-based sit-to-stand and stand-to-sit algorithm for patients with parkinson\u2019s disease and older adults in a home-like environment. Front. Neurol. 9, 652 (2018).","journal-title":"Front. Neurol."},{"key":"260_CR37","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1017\/cts.2018.4","volume":"1","author":"C Kovalchick","year":"2017","unstructured":"Kovalchick, C. et al. Can composite digital monitoring biomarkers come of age? A framework for utilization. J. Clin. Transl. Sci. 1, 373\u2013380 (2017).","journal-title":"J. Clin. Transl. Sci."},{"key":"260_CR38","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1001\/jama.2017.11295","volume":"318","author":"TR Insel","year":"2017","unstructured":"Insel, T. R. Digital phenotyping: technology for a new science of behavior. JAMA 318, 1215\u20131216 (2017).","journal-title":"JAMA"},{"key":"260_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1001\/jamacardio.2016.3340","volume":"2","author":"R Wang","year":"2017","unstructured":"Wang, R. et al. Accuracy of wrist-worn heart rate monitors. JAMA Cardiol. 2, 104 (2017).","journal-title":"JAMA Cardiol."},{"key":"260_CR40","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3233\/JPD-160898","volume":"6","author":"M Braybrook","year":"2016","unstructured":"Braybrook, M. et al. An ambulatory tremor Score for parkinson\u2019s disease. J. Parkinsons Dis. 6, 723\u2013731 (2016).","journal-title":"J. Parkinsons Dis."},{"key":"260_CR41","doi-asserted-by":"publisher","unstructured":"Panescu, D. Medical device development. in 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society 5591\u20135594 (2009). https:\/\/doi.org\/10.1109\/IEMBS.2009.5333490.","DOI":"10.1109\/IEMBS.2009.5333490"},{"key":"260_CR42","unstructured":"Commissioner, O. of the. FDA in brief: FDA seeks public feedback on biomarker and study endpoint glossary. FDA (2019)."},{"key":"260_CR43","doi-asserted-by":"publisher","unstructured":"IEEE Standard for System, Software, and Hardware Verification and Validation. IEEE Std 1012-2016 (Revision of IEEE Std 1012-2012\/ Incorporates IEEE Std 1012-2016\/Cor1-2017) 1\u2013260 (2017). https:\/\/doi.org\/10.1109\/IEEESTD.2017.8055462.","DOI":"10.1109\/IEEESTD.2017.8055462"},{"key":"260_CR44","doi-asserted-by":"publisher","unstructured":"National Academies of Sciences, Engineering, and Medicine. An Evidence Framework for Genetic Testing. (The National Academies Press, 2017). https:\/\/doi.org\/10.17226\/24632.","DOI":"10.17226\/24632"},{"key":"260_CR45","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00421-015-3303-9","volume":"116","author":"D Giles","year":"2016","unstructured":"Giles, D., Draper, N. & Neil, W. Validity of the Polar V800 heart rate monitor to measure RR intervals at rest. Eur. J. Appl. Physiol. 116, 563\u2013571 (2016).","journal-title":"Eur. J. Appl. Physiol."},{"key":"260_CR46","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1161\/01.CIR.93.5.1043","volume":"93","author":"Heart rate variability: standards of measurement, physiological interpretation and clinical use.","year":"1996","unstructured":"Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task force of the European society of cardiology and the north american society of pacing and electrophysiology. Circulation 93, 1043\u20131065 (1996).","journal-title":"Circulation"},{"key":"260_CR47","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1519\/JSC.0000000000001662","volume":"32","author":"D Hernando","year":"2018","unstructured":"Hernando, D., Garatachea, N., Almeida, R., Casaj\u00fas, J. A. & Bail\u00f3n, R. Validation of heart rate monitor polar rs800 for heart rate variability analysis during exercise. J. Strength Cond. Res. 32, 716 (2018).","journal-title":"J. Strength Cond. Res."},{"key":"260_CR48","unstructured":"Frasch, M. G. et al. Can a heart rate variability biomarker identify the presence of autism spectrum disorder in eight year old children? arXiv:1808.08306 [q-bio] (2018)."},{"key":"260_CR49","doi-asserted-by":"publisher","first-page":"531","DOI":"10.4187\/respcare.02688","volume":"59","author":"C Karpman","year":"2014","unstructured":"Karpman, C., LeBrasseur, N. K., DePew, Z. S., Novotny, P. J. & Benzo, R. P. Measuring gait speed in the out-patient clinic: methodology and feasibility. Respir. Care 59, 531\u2013537 (2014).","journal-title":"Respir. Care"},{"key":"260_CR50","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.medengphy.2014.02.006","volume":"36","author":"E Fortune","year":"2014","unstructured":"Fortune, E., Lugade, V., Morrow, M. & Kaufman, K. Validity of using tri-axial accelerometers to measure human movement \u2013 Part II: step counts at a wide range of gait velocities. Med. Eng. Phys. 36, 659\u2013669 (2014).","journal-title":"Med. Eng. Phys."},{"key":"260_CR51","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s40520-016-0703-6","volume":"29","author":"A K\u00f6nig","year":"2017","unstructured":"K\u00f6nig, A. et al. Objective measurement of gait parameters in healthy and cognitively impaired elderly using the dual-task paradigm. Aging Clin. Exp. Res 29, 1181\u20131189 (2017).","journal-title":"Aging Clin. Exp. Res"},{"key":"260_CR52","unstructured":"U.S. Department of Health and Human Services et al. Guidance for Industry and FDA Staff: Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm. (2003)."},{"key":"260_CR53","unstructured":"Apple Inc. Using Apple Watch for Arrhythmia Detection. (2018)."},{"key":"260_CR54","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1213\/ANE.0000000000002329","volume":"126","author":"B Parvinian","year":"2018","unstructured":"Parvinian, B., Scully, C., Wiyor, H., Kumar, A. & Weininger, S. Regulatory considerations for physiological closed-loop controlled medical devices used for automated critical care: food and drug administration workshop discussion topics. Anesth. Analg. 126, 1916\u20131925 (2018).","journal-title":"Anesth. Analg."},{"key":"260_CR55","doi-asserted-by":"crossref","unstructured":"Allen, N. & Gupta, A. Current Diabetes Technology: Striving for the Artificial Pancreas. Diagnostics (Basel) 9, 31 (2019).","DOI":"10.3390\/diagnostics9010031"},{"key":"260_CR56","unstructured":"The 670G System - P160017. Available at: http:\/\/wayback.archive-it.org\/7993\/20170111141252\/http:\/\/www.fda.gov\/MedicalDevices\/ProductsandMedicalProcedures\/DeviceApprovalsandClearances\/Recently-ApprovedDevices\/ucm522764.htm. (Accessed: 19th September 2019)."},{"key":"260_CR57","first-page":"631","volume":"2","author":"N Watanabe","year":"2017","unstructured":"Watanabe, N. et al. Development and Validation of a Novel Cuff-Less Blood Pressure Monitoring Device. J Am Coll Cardiol Basic Trans. JACC: Basic to Translational Science 2, 631\u2013642 (2017).","journal-title":"JACC: Basic to Translational Science"},{"key":"260_CR58","doi-asserted-by":"publisher","unstructured":"IEEE Standard for Wearable Cuffless Blood Pressure Measuring Devices. IEEE Std 1708-2014 1\u201338 (2014). https:\/\/doi.org\/10.1109\/IEEESTD.2014.6882122.","DOI":"10.1109\/IEEESTD.2014.6882122"},{"key":"260_CR59","unstructured":"International Organization for Standardization & International Electrotechnical Commission. ANSI\/AAMI\/ISO 81060-2:2013: Non-invasive sphygmomanometers \u2014 Part 2: Clinical investigation of automated measurement type."},{"key":"260_CR60","unstructured":"IEEE standard for software verification and validation. (Institute of Electrical and Electronics Engineers, 1998)."},{"key":"260_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-019-0084-2","volume":"2","author":"LC Kourtis","year":"2019","unstructured":"Kourtis, L. C., Regele, O. B., Wright, J. M. & Jones, G. B. Digital biomarkers for Alzheimer\u2019s disease: the mobile\/wearable devices opportunity. Npj Digit. Med. 2, 1\u20139 (2019).","journal-title":"Npj Digit. Med."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-020-0260-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-020-0260-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-020-0260-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T21:09:33Z","timestamp":1670360973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-020-0260-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,14]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["260"],"URL":"https:\/\/doi.org\/10.1038\/s41746-020-0260-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.17264","asserted-by":"object"}]},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,14]]},"assertion":[{"value":"22 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This collaborative manuscript was developed as part of research initiatives led by the Digital Medicine Society (DiMe). All authors are members of DiMe. DiMe is a Massachusetts non-profit corporation with 501(c)(3) application pending. J.C.G. is a part-time employee of HealthMode, Inc. A.C. is founder of Elektra Labs. E.I. is an executive of Koneksa Health. J.P.B. is a full-time employee of Philips.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"55"}}